遗传性脑小血管病的管理:以CADASIL为例:美国心脏协会科学声明
该科学声明以常染色体显性遗传性脑动脉病伴皮质下梗死和白质脑病(CADASIL)为例,回顾其临床、遗传和影像学特征,并与其他遗传性脑小血管病对比。声明旨在提供关键的预防、管理和治疗考量,以减少实践差异并鼓励产生高质量证据以支持未来治疗推荐。
要点
- CADASIL是最常见的遗传性脑小血管病,以腔隙性梗死和血管性痴呆为重要表型特征。
- 症状性质和发病年龄及进展速度存在变异性,仅部分由NOTCH3基因致病突变差异解释。
- 早期识别疾病并获取分子诊断是重要临床目标,尽管缺乏证实的疾病修饰治疗。
核心结论
- 声明回顾了CADASIL的临床、遗传和影像学方面,与其他遗传性脑小血管病对比,并提供预防、管理和治疗考量以减少实践差异。
研究设计与样本
- 美国心脏协会科学声明,以CADASIL为例。
主要发现
- CADASIL是最常见的遗传性脑小血管病,以腔隙性梗死和血管性痴呆为重要表型特征。
- 症状性质和发病年龄及进展速度存在变异性,仅部分由NOTCH3基因致病突变差异解释。
- 早期识别疾病并获取分子诊断是重要临床目标,尽管缺乏证实的疾病修饰治疗。
临床怎么用
- 提供关键的预防、管理和治疗考量,以减少实践差异并鼓励产生高质量证据以支持未来治疗推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lacunar infarcts and vascular dementia are important phenotypic characteristics of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, the most common inherited cerebral small vessel disease. Individuals with the disease show variability in the nature and onset of symptoms and rates of progression, which are only partially explained by differences in pathogenic mutations in the NOTCH3 gene. Recognizing the disease early in its course and securing a molecular diagnosis are important clinical goals, despite the lack of proven disease-modifying treatments. The purposes of this scientific statement are to review the clinical, genetic, and imaging aspects of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, contrasting it with other inherited small vessel diseases, and to provide key prevention, management, and therapeutic considerations with the intent of reducing practice variability and encouraging production of high-quality evidence to support future treatment recommendations.
引用
- Meschia JF, Worrall BB, Elahi FM, et al. Management of Inherited CNS Small Vessel Diseases: The CADASIL Example: A Scientific Statement From the American Heart Association. Stroke. 2023. PMID: 37602377. doi:10.1161/STR.0000000000000444
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。